Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 7Paclitaxel 6Radiotherapy 5Cisplatin 4Bevacizumab 4Cetuximab 2Amplified Fragment Length Polymorphism Analysis 2pegfilgrastim 1advexin 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy, Conformal 1Radiosurgery 1Polymerase Chain Reaction 1Pneumonectomy 1Pharmacogenomic Testing 1Pemetrexed 1Panitumumab 1Neoadjuvant Therapy 1Injections 1Immunohistochemistry 1Glutamic Acid 1Gene Expression Profiling 1Gemcitabine 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Docetaxel 1Chromosome Mapping 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma, Bronchiolo-Alveolar × Anterior Temporal Lobectomy × Clear all
NCT00979212 2022-06-15

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 2 Completed
71 enrolled 11 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡